ASX Slides on Oil Surge, CSL Cuts US Prices

CSL discounts drugs in US after Trump tariff threats

The Australian biotech giant has agreed to sell drugs at a discount in the US under the Trump administration’s affordable medicines blitz and formalised plans to expand manufacturing in America.

CSL signs deal with Trump administration to slash prices for its medicines

Australia’s largest pharma company has agreed to lower the cost of its medicines in the US as it seeks to avoid the 100 per cent tariffs slapped on Australian-made pharmaceuticals.

CSL agrees to lower prices in sweeping Trump administration deal

CSL and eight other pharmaceutical companies will be forced to cut medicine costs for some US patients, following pressure from the Trump administration.

ASX Slides on Oil Surge, CSL Cuts US Prices

The Australian share market experienced a downturn today as rising oil prices and climbing bond yields impacted investor sentiment. The S&P/ASX 200 index saw shares fall, with crude oil topping US$90 a barrel. Concurrently, Australian 10-year bond yields surged, reflecting broader global economic pressures. Tech stocks, in particular, faced declines during the session, though Austal